S Shakya, J Edwards, H A Gupte, S Shrestha, B M Shakya, K Parajuli, H P Kattel, P S Shrestha, R Ghimire, P Thekkur
{"title":"尼泊尔加德满都一家三级医院尿路感染的高多药耐药性。","authors":"S Shakya, J Edwards, H A Gupte, S Shrestha, B M Shakya, K Parajuli, H P Kattel, P S Shrestha, R Ghimire, P Thekkur","doi":"10.5588/pha.21.0035","DOIUrl":null,"url":null,"abstract":"<p><strong>Setting: </strong>Tribhuvan University Teaching Tertiary Care Hospital, Kathmandu, Nepal, May-October 2019.</p><p><strong>Objective: </strong>1) To describe the bacteriological profile, 2) to identify the antimicrobial resistance (AMR) pattern, and 3) to find the demographic characteristics associated with the presence of bacterial growth and multidrug resistance (MDR) in adult urine samples undergoing culture and drug susceptibility testing.</p><p><strong>Design: </strong>This was a hospital-based, cross-sectional study using routine laboratory records.</p><p><strong>Results: </strong>Among 11,776 urine samples, 16% (1,865/11,776) were culture-positive, predominantly caused by <i>Escherichia coli</i> (1,159/1,865; 62%). We found a high prevalence of resistance to at least one antibiotic (1,573/1,865; 84%) and MDR (1,000/1,865; 54%). Resistance to commonly used antibiotics for urinary tract infections (UTIs) such as ceftazidime, levofloxacin, cefepime and ampicillin was high. Patients aged ⩾60 years (adjusted prevalence ratio [aPR] 1.6, 95% CI 1.4-1.7) were more likely to have culture positivity. Patients with age ⩾45 years (45-59 years: aPR 1.5, 95% CI 1.3-1.7; ⩾60 years: aPR 1.4, 95% CI 1.2-1.6), male sex (aPR 1.3, 95% CI 1.2-1.5) and from inpatient settings (aPR 1.4, 95% CI 1.2-1.7) had significantly higher prevalence of MDR.</p><p><strong>Conclusion: </strong>Urine samples from a tertiary hospital showed high prevalence of <i>E. coli</i> and MDR to routinely used antibiotics, especially among inpatients. Regular surveillance and application of updated antibiograms are crucial to monitor the AMR situation in Nepal.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"11 Suppl 1","pages":"24-31"},"PeriodicalIF":1.3000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575380/pdf/","citationCount":"5","resultStr":"{\"title\":\"High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal.\",\"authors\":\"S Shakya, J Edwards, H A Gupte, S Shrestha, B M Shakya, K Parajuli, H P Kattel, P S Shrestha, R Ghimire, P Thekkur\",\"doi\":\"10.5588/pha.21.0035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Setting: </strong>Tribhuvan University Teaching Tertiary Care Hospital, Kathmandu, Nepal, May-October 2019.</p><p><strong>Objective: </strong>1) To describe the bacteriological profile, 2) to identify the antimicrobial resistance (AMR) pattern, and 3) to find the demographic characteristics associated with the presence of bacterial growth and multidrug resistance (MDR) in adult urine samples undergoing culture and drug susceptibility testing.</p><p><strong>Design: </strong>This was a hospital-based, cross-sectional study using routine laboratory records.</p><p><strong>Results: </strong>Among 11,776 urine samples, 16% (1,865/11,776) were culture-positive, predominantly caused by <i>Escherichia coli</i> (1,159/1,865; 62%). We found a high prevalence of resistance to at least one antibiotic (1,573/1,865; 84%) and MDR (1,000/1,865; 54%). Resistance to commonly used antibiotics for urinary tract infections (UTIs) such as ceftazidime, levofloxacin, cefepime and ampicillin was high. Patients aged ⩾60 years (adjusted prevalence ratio [aPR] 1.6, 95% CI 1.4-1.7) were more likely to have culture positivity. Patients with age ⩾45 years (45-59 years: aPR 1.5, 95% CI 1.3-1.7; ⩾60 years: aPR 1.4, 95% CI 1.2-1.6), male sex (aPR 1.3, 95% CI 1.2-1.5) and from inpatient settings (aPR 1.4, 95% CI 1.2-1.7) had significantly higher prevalence of MDR.</p><p><strong>Conclusion: </strong>Urine samples from a tertiary hospital showed high prevalence of <i>E. coli</i> and MDR to routinely used antibiotics, especially among inpatients. Regular surveillance and application of updated antibiograms are crucial to monitor the AMR situation in Nepal.</p>\",\"PeriodicalId\":46239,\"journal\":{\"name\":\"Public Health Action\",\"volume\":\"11 Suppl 1\",\"pages\":\"24-31\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575380/pdf/\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Public Health Action\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5588/pha.21.0035\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health Action","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5588/pha.21.0035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 5
摘要
地点:2019年5月至10月,尼泊尔加德满都特里布万大学三级教学医院。目的:1)描述细菌学特征;2)鉴定抗微生物药物耐药性(AMR)模式;3)通过培养和药敏试验,发现成人尿液样本中细菌生长和多药耐药(MDR)相关的人口学特征。设计:这是一项基于医院的横断面研究,使用常规实验室记录。结果:11776份尿样中,培养阳性占16%(1865 / 11776),主要由大肠杆菌引起(1159 / 1865;62%)。我们发现对至少一种抗生素的耐药性很高(1,573/1,865;84%)和耐多药(1000 / 1865;54%)。对头孢他啶、左氧氟沙星、头孢吡肟、氨苄西林等尿路感染常用抗生素的耐药性较高。年龄大于或等于60岁的患者(调整患病率[aPR] 1.6, 95% CI 1.4-1.7)更有可能具有培养阳性。年龄大于或等于45岁的患者(45-59岁:aPR 1.5, 95% CI 1.3-1.7;小于或等于60年:aPR 1.4, 95% CI 1.2-1.6),男性(aPR 1.3, 95% CI 1.2-1.5)和住院环境(aPR 1.4, 95% CI 1.2-1.7)具有显着更高的MDR患病率。结论:某三级医院尿样中大肠杆菌和耐多药感染率较高,住院患者尤甚。定期监测和应用更新的抗生素图对于监测尼泊尔的抗生素耐药性情况至关重要。
High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal.
Setting: Tribhuvan University Teaching Tertiary Care Hospital, Kathmandu, Nepal, May-October 2019.
Objective: 1) To describe the bacteriological profile, 2) to identify the antimicrobial resistance (AMR) pattern, and 3) to find the demographic characteristics associated with the presence of bacterial growth and multidrug resistance (MDR) in adult urine samples undergoing culture and drug susceptibility testing.
Design: This was a hospital-based, cross-sectional study using routine laboratory records.
Results: Among 11,776 urine samples, 16% (1,865/11,776) were culture-positive, predominantly caused by Escherichia coli (1,159/1,865; 62%). We found a high prevalence of resistance to at least one antibiotic (1,573/1,865; 84%) and MDR (1,000/1,865; 54%). Resistance to commonly used antibiotics for urinary tract infections (UTIs) such as ceftazidime, levofloxacin, cefepime and ampicillin was high. Patients aged ⩾60 years (adjusted prevalence ratio [aPR] 1.6, 95% CI 1.4-1.7) were more likely to have culture positivity. Patients with age ⩾45 years (45-59 years: aPR 1.5, 95% CI 1.3-1.7; ⩾60 years: aPR 1.4, 95% CI 1.2-1.6), male sex (aPR 1.3, 95% CI 1.2-1.5) and from inpatient settings (aPR 1.4, 95% CI 1.2-1.7) had significantly higher prevalence of MDR.
Conclusion: Urine samples from a tertiary hospital showed high prevalence of E. coli and MDR to routinely used antibiotics, especially among inpatients. Regular surveillance and application of updated antibiograms are crucial to monitor the AMR situation in Nepal.
期刊介绍:
Launched on 1 May 2011, Public Health Action (PHA) is an official publication of the International Union Against Tuberculosis and Lung Disease (The Union). It is an open access, online journal available world-wide to physicians, health workers, researchers, professors, students and decision-makers, including public health centres, medical, university and pharmaceutical libraries, hospitals, clinics, foundations and institutions. PHA is a peer-reviewed scholarly journal that actively encourages, communicates and reports new knowledge, dialogue and controversy in health systems and services for people in vulnerable and resource-limited communities — all topics that reflect the mission of The Union, Health solutions for the poor.